Effect of Sweetness Intensity of a Sucrose Solution on Blood Glucose Regulation and Energy Intake

NCT ID: NCT04991714

Last Updated: 2023-01-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

EARLY_PHASE1

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-08-05

Study Completion Date

2022-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study is to investigate the influence of the modulation of the sweetness intensity of a carbohydrate (sucrose)-containing solution on metabolic effects, in particular the regulation of blood glucose concentration and regulation of hunger \& satiety.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is designed as a randomised cross-over intervention study with four interventions. The study investigates the influence of sweetness modulation by Rebaudioside M (sweetness enhancement) and Lactisol (sweetness inhibition) of a 10% sucrose solution, corresponding to the concentration of a regular soft drink, on blood glucose regulation (blood glucose concentration and regulating hormones) in healthy male volunteers. Furthermore, the study assesses ad libitum energy intake, individual feelings of hunger and satiety, metabolic responses to the interventions, and preference for sweet-tasting foods such as sugar and sweeteners. In addition, the participants' individual thresholds for sweet taste, as well as morphological markers for taste sensitivity and body composition will be recorded as potential influencing factors.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Glucose, Low Hunger

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sucrose

10% solution in water

Group Type EXPERIMENTAL

Sucrose

Intervention Type OTHER

10% Sucrose corresponding to a regular soft drink

Sucrose + Reb M

10% sucrose + 60 mg/L Rebaudioside M

Group Type EXPERIMENTAL

Rebaudioside M

Intervention Type DRUG

Sweetener (increases sweetness)

Sucrose

Intervention Type OTHER

10% Sucrose corresponding to a regular soft drink

Sucrose + Lactisole

10% sucrose + 30 mg/ L Lactisole

Group Type EXPERIMENTAL

Lactisole

Intervention Type DRUG

sweet taste inhibitor (decreases sweetness)

Sucrose

Intervention Type OTHER

10% Sucrose corresponding to a regular soft drink

Sucrose + Reb M + Lactisole

10% sucrose + 60 mg/L Rebaudioside M + 30 mg/ L Lactisole

Group Type EXPERIMENTAL

Lactisole

Intervention Type DRUG

sweet taste inhibitor (decreases sweetness)

Rebaudioside M

Intervention Type DRUG

Sweetener (increases sweetness)

Sucrose

Intervention Type OTHER

10% Sucrose corresponding to a regular soft drink

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lactisole

sweet taste inhibitor (decreases sweetness)

Intervention Type DRUG

Rebaudioside M

Sweetener (increases sweetness)

Intervention Type DRUG

Sucrose

10% Sucrose corresponding to a regular soft drink

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

2-(4-methoxyphenoxy)propionic acid CAS Number: 150436-68-3 CAS Number: 1220616-44-3 table sugar

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* male
* healthy
* non-smoking
* normal taste responses towards sweet taste

Exclusion Criteria

* female
* regular smokers
* disturbed glucose and/or lipid metabolism
* regular intake of medication
* known allergies against one of the test compounds
* ageusia
* alcohol or drug addiction
* intake of antibiotics within the past 2 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Vienna

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Barbara Lieder

Deptuy Head Department of Physiological Chemistry

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Barbara Lieder, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Vienna

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Christian Doppler Laboratory for Taste Research

Vienna, , Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

706014-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Glucose and Motivation States
NCT07255183 RECRUITING NA